Atlas Arteria is a toll roads owner, operator, and developer.
The company owns five toll roads in France, Germany, and the United States.
This year, Atlas Arteria shares paid investors an unfranked annual dividend of 40 cents per share.
According to analyst predictions published on CommSec, Atlas Arteria is expected to pay 37 cents per share in 2027.
Based on today’s share price, that equates to a dividend yield of 9.7%.
That’s more than twice the average 4.2% yield delivered by the S&P/ASX 200 Index (ASX: XJO) last financial year.
How much is that in dividends?
If I bought $15,000 worth of Atlas Arteria shares today, I’d own 3,926 shares.
If the experts are right, and I were to receive 37 cents per share in dividends in 2027, that would equate to $1,452.62.
The experts have also provided a dividend prediction for 2028.
They expect Atlas Arteria shares to pay 44 cents per share in dividends.
On a $15,000 investment, that would give me $1,727.44 in dividends.
That equates to a dividend yield of 11.5%.
Do the experts recommend Atlas Arteria shares?
Atlas Arteria shares have paid 40 cents per share in annual dividends since 2022.
However, that doesn’t guarantee anything about the future.
Before you buy a stock for income, you have to do your research and feel satisfied that the dividend yield is sustainable long term.
Before you start that process, let’s take a look at some expert ratings on the stock.
Morgans has a hold rating on Atlas Arteria shares with a 12-month share price forecast of $4.74.
That implies about 24% potential upside ahead.
In a note, Morgans noted the possibility that IFM Investors might be back with another takeover offer.
IFM offered $4.75 per share in April, with a promise to increase it to $5.10 if its stake rose above 45% by the offer’s closing date.
The Atlas Arteria board rejected the offer.
The offer period closed in July, by which point IFM has increased its stake from 34.5% to 67.4%.
Citi also has a hold rating on Atlas Arteria shares with a 12-month target of $4.80, implying 26% upside ahead.
RBC Capital has a sell rating with a $3.60 target, suggesting a 6% downside ahead.
Macquarie gives Atlas Arteria shares a buy rating with a $4.75 target.
Atlas Arteria share price snapshot
The Atlas Arteria share price has fallen 20% over 12 months and 37% over five years.
The post If I invest $15,000 in Atlas Arteria shares, how much would I get in dividends? appeared first on The Motley Fool Australia.
Should you invest $1,000 in Atlas Arteria right now?
Before you buy Atlas Arteria shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Atlas Arteria wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 1 August 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Here are the top 10 ASX 200 shares today
- Atlas Arteria flags French tax hikes may impact toll road revenues
- How much is needed in superannuation for $1500 in weekly passive income?
- How much superannuation do I need to earn $1,000 per week in passive income?
- 5 things to watch on the ASX 200 on Wednesday
Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.